DiaMedica Therapeutics Inc.

• DiaMedica announces enrollment of 200th patient in ReMEDy2 Phase 2/3 trial
  TipRanks · 23 Oct 2026
• DiaMedica Therapeutics Reaches Patient Enrollment Milestone for Phase 2/3 Trial of DM199 in Acute Ischemic Stroke
  marketscreener.com · 22 Oct 2026
• DiaMedica Therapeutics reaches 200 patients in pivotal stroke trial
  Mugglehead Investment Magazine · 22 Oct 2026
• Diamedica Therapeutics Announces Enrollment Of 200Th Patient In Remedy2 Phase 2/3 Acute Ischemic Stroke Trial
  TradingView · 22 Oct 2026
• DiaMedica Therapeutics Announces Enrollment of 200th Patient in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial
  Business Wire · 22 Oct 2026
• DiaMedica Therapeutics Q2 2026 Earnings: Narrower-Than-Expected Loss Keeps Clinical Story on Track
  https://www.siam.in/ · 11 Oct 2026
• DiaMedica to host event on fetal growth restriction treatment By Investing.com
  Investing.com UK · 30 Sep 2026
• DiaMedica (DMAC) Surged +2.64%: Here's What Analysts Are Saying 2026-09-28 - Fibonacci Extension
  https://www.siam.in/ · 28 Sep 2026
• DiaMedica Therapeutics (NasdaqCM:DMAC) Stock Forecast & Analyst Predictions
  Simply Wall Street · 24 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →